PPD brings extensive experience in the nuances of post-approval studies, combined with a solid foundation in late-stage clinical trials management.
Experience across a broad range of indications and an investigator network of more than 6,000 cardiologists.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
View all of PPD's news releases.
Elisha Talley-Roithner, global head of operations, PPD Biotech, discusses PPD Biotech’s Biotech University and its unique training capabilities.
By Dave Agrella, vice president, functional service partnerships (FSP) and Timothy King, DrPH, executive director, FSP.
Gary Barker, Denise Moody, Magda Santos and April Pierce provide insight into creating and keeping a successful pharmacovigilance partnership with a functional service provider.
We want to hear from you
Register in PPD's Database
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.